Hans Schikan

Hans Schikan is the Non-Executive Chairman of Microbiotica. He has decades of commercial, development, transactional as well as leadership experience from the biopharma industry. Hans is a well-established biopharma leader, having held many board memberships for both private and publicly listed companies throughout his career. He currently serves on the boards of Pharvaris NV, VectivBio AG, Vicore Pharma AB, Complix NV, InteRNA Technologies BV, and the Dutch Top Sector Life Sciences and Health.

Previously Hans served as Chief Executive Officer of Prosensa where he led the Company’s $90m IPO on NASDAQ, before successfully completing the Company’s up to $840m acquisition by BioMarin. Prior to his time at Prosensa, Hans was at Genzyme, where he served as Vice President of Global Marketing and Strategic Development. Before joining Genzyme, he spent 17 years at Organon, both at a corporate level and in-country operations which included assignments in Asia and Europe. He holds a PharmD degree from the University of Utrecht.